PI3K Delta Kinase Inhibitors (Incozen Therapeutics)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NamePI3K Delta Kinase Inhibitors (Incozen Therapeutics)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphatidylinositol 3 kinase delta inhibitors
TargetsPhosphatidylinositol 3 kinase delta
Therapy Area/IndicationsPulmonary Disease, Chronic ObstructiveAsthmaArthritis, Rheumatoid +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndia
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesIncozen Therapeutics Pvt Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIncozen Therapeutics Pvt Ltd
Active IndicationsN/A
Inactive IndicationsPulmonary Disease, Chronic ObstructiveAsthmaArthritis, Rheumatoid +[4] 

Other Information

ATC CodeN/A
Related LinksN/A